Partner Headlines - BCRX

  1. 6 Movers To Keep An Eye On Next Week

    Benzinga
  2. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX443 ...

    Benzinga
  3. Benzinga's Top Upgrades

    Benzinga
  4. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga
  5. Tekmira falls on Ebola news

    IBD
  6. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD
  7. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga
  8. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  9. BioCryst Announces Initiation of a Phase 1 Clinical Trial of ...

    Benzinga
  10. Benzinga's Top Initiations

    Benzinga
  11. Benzinga's Top Upgrades

    Benzinga
  12. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected ...

    Benzinga
  13. Benzinga's Top #PreMarket Gainers

    Benzinga
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  15. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  16. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  17. BioCryst Pharmaceuticals'

    IBD
  18. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  21. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  22. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals ...

    Benzinga
  23. Ebola Vaccine Contenders

    Benzinga
  24. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  25. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  26. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  27. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  28. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  29. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  30. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  31. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  32. Benzinga's Top #PreMarket Gainers

    Benzinga
  33. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  34. Making Money With Charles Payne: 10/0614

    FoxBusiness
  35. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  36. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  37. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  38. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  39. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  40. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  41. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  42. Morning Market Movers

    Benzinga
  43. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  44. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  45. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  46. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  47. Momentum Stocks Showing Weakness

    Benzinga
  48. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  49. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  50. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  51. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  52. Biotechs That Might Benefit From Ebola

    Benzinga
  53. Benzinga's Top #PreMarket Gainers

    Benzinga
  54. Stocks Hitting 52-Week Highs

    Benzinga
  55. Benzinga's Top Initiations

    Benzinga
  56. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  57. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  58. Ebola Stocks Continue Higher

    Benzinga
  59. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  60. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  61. Benzinga's Top Initiations

    Benzinga
  62. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  63. Benzinga's Top #PreMarket Gainers

    Benzinga
  64. Benzinga's Top Downgrades

    Benzinga
  65. Benzinga's Top Initiations

    Benzinga
  66. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  67. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  68. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  69. Benzinga's Top #PreMarket Gainers

    Benzinga
  70. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  71. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  72. Benzinga's Top Pre-Market Gainers

    Benzinga
  73. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  74. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  75. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  76. Benzinga's Top Pre-Market Gainers

    Benzinga
  77. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  78. Benzinga's Top Pre-Market Gainers

    Benzinga
  79. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  80. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  81. Benzinga's Top Pre-Market Losers

    Benzinga
  82. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  83. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  84. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  85. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  86. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  87. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  88. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  89. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  90. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  91. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  92. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  93. A Peek Into The Market Before The Trading Starts

    Benzinga
  94. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  95. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  96. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  97. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  98. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  99. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  100. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!